SyntheticMR AB (publ) (SYNT.ST)
Stockholm · SEK · Healthcare · Health Information Services
SEK 0.618 (+3.00%) as of
Key statistics
- Market cap
- 55.21M
- Forward P/E
- -5.26
- EPS (TTM)
- -0.6500
- Dividend yield
- 0.00%
- 52-week range
- 0.4260 – 2.4300
- Beta
- 0.85
- Revenue (TTM)
- 57.49M
- Profit margin
- -75.69%
- Analyst target
- SEK 0.80
- Volume
- 70.96k
About SyntheticMR AB (publ)
SyntheticMR AB (publ) engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. The company also offers SyMRI NEURO, which includes multiple contrast images, automatic segmentation, volumetric measurements and quantitative maps of the patients; SyMRI Spine & Knee; SyMRI MSK Spine and SyMRI Knee that offers a solution in obtaining anatomical information from a single MRI sequence; and cNeuro, a platform for interdisciplinary clinical work in radiology, neurology, and nuclear medicine. It sells its products to the Americas, Europe, Japan, and India. The company was incorporated in 2007 and is based in Linköping, Sweden.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Linköping, Sweden
- Employees
- 37
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.